BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10464014)

  • 21. Synthesis of 4,5-functionalized-2-methyl-6-(substituted aryl)-3 (2H)-pyridazinones: a new group of potent platelet aggregation inhibitors.
    Dal Piaz V; Ciciani G; Giovannoni MP
    Farmaco; 1997 Mar; 52(3):173-8. PubMed ID: 9212451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Benzimidazo-pyrimidino-imidazo-thiadiazines pharmacologically active].
    Rusu G; Profire L; Dănilă G
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(1):274-8. PubMed ID: 21495330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: design, synthesis, and SAR studies.
    Meyers C; Yáñez M; Elmaatougi A; Verhelst T; Coelho A; Fraiz N; Lemière GL; García-Mera X; Laguna R; Cano E; Maes BU; Sotelo E
    Bioorg Med Chem Lett; 2008 Jan; 18(2):793-7. PubMed ID: 18053717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solubilized phenyl-pyrazole ureas as potent, selective 5-HT(2A) inverse-agonists and their application as antiplatelet agents.
    Dosa PI; Strah-Pleynet S; Jayakumar H; Casper M; Decaire M; Xiong Y; Lehmann J; Choi K; Elwell K; Wong A; Webb RR; Adams JW; Ramirez J; Richman JG; Thomsen W; Semple G; Teegarden BR
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5486-9. PubMed ID: 19665894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 1: design and synthesis of a lead compound exhibiting alpha(v)beta3/alpha(IIb)beta3 dual antagonistic activity.
    Kubota D; Ishikawa M; Yamamoto M; Murakami S; Hachisu M; Katano K; Ajito K
    Bioorg Med Chem; 2006 Apr; 14(7):2089-108. PubMed ID: 16309911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, antileukemic and antiplatelet activities of 2,3-diaryl-6,7-dihydro-5H-1,4-diazepines.
    Ramajayam R; Giridhar R; Yadav MR; Balaraman R; Djaballah H; Shum D; Radu C
    Eur J Med Chem; 2008 Sep; 43(9):2004-10. PubMed ID: 18191304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel tricyclic benzothiazolo[2,3-c]thiadiazine antagonists of the platelet ADP receptor (P2Y(12)).
    Scarborough RM; Laibelman AM; Clizbe LA; Fretto LJ; Conley PB; Reynolds EE; Sedlock DM; Jantzen H
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1805-8. PubMed ID: 11459636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
    Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
    Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists.
    Clasby MC; Chackalamannil S; Czarniecki M; Doller D; Eagen K; Greenlee WJ; Lin Y; Tsai H; Xia Y; Ahn HS; Agans-Fantuzzi J; Boykow G; Chintala M; Foster C; Bryant M; Lau J
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1544-8. PubMed ID: 16380251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, resolution, and antiplatelet activity of 3-substituted 1(3H)-isobenzofuranone.
    Yang H; Hu GY; Chen J; Wang Y; Wang ZH
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5210-3. PubMed ID: 17632002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New 2-amino-thiazole-4-acetamides with antiplatelet activity.
    Rehse K; Baselt T
    Arch Pharm (Weinheim); 2008 Oct; 341(10):645-54. PubMed ID: 18720337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel bronchodilators: synthesis, transamination reactions, and pharmacology of a series of pyrazino[2,3-c][1,2,6]thiadiazine 2, 2-dioxides.
    Campillo N; García C; Goya P; Alkorta I; Páez JA
    J Med Chem; 2000 Nov; 43(22):4219-27. PubMed ID: 11063618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site.
    Roma G; Di Braccio M; Grossi G; Piras D; Leoncini G; Bruzzese D; Signorello MG; Fossa P; Mosti L
    J Med Chem; 2007 Jun; 50(12):2886-95. PubMed ID: 17500510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New pyrimido[5,4-c]cinnolines with antiplatelet activities.
    Rehse K; Gonska H
    Arch Pharm (Weinheim); 2005 Dec; 338(12):590-7. PubMed ID: 16281308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tetrahydro-4-quinolinamines identified as novel P2Y(1) receptor antagonists.
    Morales-Ramos AI; Mecom JS; Kiesow TJ; Graybill TL; Brown GD; Aiyar NV; Davenport EA; Kallal LA; Knapp-Reed BA; Li P; Londregan AT; Morrow DM; Senadhi S; Thalji RK; Zhao S; Burns-Kurtis CL; Marino JP
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6222-6. PubMed ID: 18926700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationship study on the 6-membered heteroaromatic ring system of diphenylpyrazine-type prostacyclin receptor agonists.
    Asaki T; Hamamoto T; Sugiyama Y; Kuwano K; Kuwabara K; Niwa T
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6588-92. PubMed ID: 17920266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel 3,6-disubstituted 7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazines: synthesis, characterization, and evaluation of analgesic/anti-inflammatory, antioxidant activities.
    Tozkoparan B; Aytaç SP; Aktay G
    Arch Pharm (Weinheim); 2009 May; 342(5):291-8. PubMed ID: 19415660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative structure-activity relationship study of fibrinogen inhibitors, [[4-(4-amidinophenoxy)butanoyl]aspartyl]valine (FK633) derivatives, using a novel hydrophobic descriptor.
    Tanaka A; Fujiwara H
    J Med Chem; 1996 Dec; 39(25):5017-20. PubMed ID: 8960563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-substituted pyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides. A new class of diuretics.
    Goya P; Paez JA; Alkorta I; Carrasco E; Grau M; Anton F; Julia S; Martinez-Ripoll M
    J Med Chem; 1992 Oct; 35(22):3977-83. PubMed ID: 1433206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of isoquinoline alkaloids of different structural types on antiplatelet aggregation in vitro.
    Chia YC; Chang FR; Wu CC; Teng CM; Chen KS; Wu YC
    Planta Med; 2006 Oct; 72(13):1238-41. PubMed ID: 16981134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.